STOCK TITAN

MDB Capital (NASDAQ: MDBH) names Jeb Terry independent director as long-time member retires

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

MDB Capital Holdings, LLC reported changes to its board of directors. Effective February 1, 2026, the board appointed Jeb Terry Sr. as an independent director and member of the audit committee, citing his long experience investing in microcap medical and biotechnology companies.

As director compensation, Mr. Terry will receive an annual cash payment of $50,000 and an option to acquire up to 100,000 Class A Shares under the 2022 Equity Incentive Plan. Of these, 20,000 Class A Shares vest on the first anniversary of the grant date, then 5,000 Class A Shares vest at the end of each three-month period thereafter, subject to continued service.

The company also disclosed that long-serving director Susanne Meline resigned from the board effective February 1, 2026 to pursue retirement, and the board expressed appreciation for her years of service.

Positive

  • None.

Negative

  • None.

Insights

MDBH refreshes its board with a new independent director while a long-serving member retires.

MDB Capital Holdings added Jeb Terry Sr. as an independent director and audit committee member effective February 1, 2026. His background spans venture capital, leveraged buyouts, and microcap life sciences investing, which aligns with the company’s focus on smaller, innovation-driven companies.

The filing states he is considered both an independent director under Nasdaq standards and a “financial expert,” which can strengthen audit oversight. His compensation combines a $50,000 annual cash payment with options for up to 100,000 Class A Shares, vesting over time with continued board service.

On the same date, long-time director Susanne Meline resigned to pursue retirement. The change represents ordinary board refreshment rather than a disclosed dispute, so the overall impact on the company’s fundamentals appears routine and governance-focused rather than transformational.

false 0001934642 0001934642 2026-02-02 2026-02-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

Current Report Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

 

February 2, 2026

 

MDB Capital Holdings, LLC

(Exact name of registrant as specified in its charter)

 

Delaware   001-41751   87-4366624
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

14135 Midway Road, Suite G-150

Addison, TX 75001

(Address of principal executive offices and zip code)

 

Registrant’s telephone number, including area code: (945) 262-9010

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Shares, representing Limited Liability Interests   MDBH   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 
 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

Appointment of Director – Jeb Terry

 

Effective February 1, 2026, the Board of Directors (the “Board”) of MDB Capital Holdings, LLC (the “Company”) appointed Mr. Jeb Terry Sr., age 73, as an independent director. Mr. Terry will also serve as a member of the audit committee of the Board. Mr. Terry’s initial term as a director will expire on the date of the Company’s next annual meeting of stockholders and until his successor shall be elected and qualified or until his earlier death, resignation, retirement, disqualification or removal.

 

Mr. Terry is a seasoned investor with more than 20 years of expertise in microcap medical and biotechnology companies, where he has consistently identified and capitalized on high-potential opportunities in this dynamic and innovation-driven sector. Drawing on a career spanning venture capital, leveraged buyouts, emerging international markets, and public equities, Mr. Terry brings a multifaceted perspective to investment decision-making.

 

Since January 1, 2026, Mr. Terry has managed his personal family office and is also currently managing the Wilson Foundation since December 2015. Previously, Mr. Terry founded and served as President of Aberdeen Investment Management LLC from September 2010 through December 31, 2025, where he led investment strategy and portfolio management with a sharp focus on undervalued microcap opportunities in life sciences. Prior to founding Aberdeen Investment Management, Mr. Terry held senior roles at a top-20 commercial bank, advised ultra-high-net-worth family offices, and worked within a bulge-bracket investment bank. Mr. Terry was a principal in venture capital and private equity and founded and managed a hedge fund specializing in dynamic hedging strategies for concentrated public holdings on behalf of large family office clients.

 

Mr. Terry holds an MBA from Columbia Business School and a BBA from Southern Methodist University.

 

The Board has determined that Mr. Terry qualifies as an independent director under the corporate governance standards of Nasdaq, and that there are no arrangements or understandings between Mr. Terry and any other person pursuant to which he was elected as a director. There are no transactions in which Mr. Terry has an interest requiring disclosure under Item 404(a) of Regulation S-K.

 

Mr. Terry was appointed to be a member of the Board due to his education and extensive experience as an RIA, investing in small capital companies, and sourcing investment opportunities for Public Ventures, LLC. Mr. Terry is also determined by reason of is extensive investment experience and business operational experience to be a “financial expert.”

 

As compensation for his service on the Board and any committees thereof, Mr. Terry will receive an annual cash payment of $50,000, and an option award under the Company’s 2022 Equity Incentive Plan to acquire up to 100,000 Class A Shares, of which 20,000 of the Class A shares vest on the first anniversary of the grant date, then 5,000 of the Class A shares vest at the end of each 3 months thereafter, provided that Mr. Terry is in the position of the directorship through and on the date(s) of vesting. Mr. Terry will be reimbursed usual and reasonable expenses incurred in the performance of his duties as a director. The Class A Shares will be subject to the clawback policy of the Company.

 

Resignation of Susanne Meline

 

Effective February 1, 2026, after serving on the Board for many years, Ms. Meline has offered her resignation from the Board as she begins to pursue her general retirement, which was accepted by the Board with much regret and heartfelt thanks.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Name of Exhibit
     
104   Cover Page Interactive Data File (embedded within the inline XBRL document).

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 2, 2026 MDB Capital Holdings, LLC
     
  By /s/ Mo Hayat
    Mo Hayat
   

Head of Corporate Development and Chief Legal Officer

 

 

 

FAQ

What board changes did MDBH disclose in this 8-K filing?

MDB Capital Holdings reported appointing Jeb Terry Sr. as an independent director and audit committee member effective February 1, 2026, while long-serving director Susanne Meline resigned the same day to pursue retirement, indicating a routine board refresh rather than a dispute-driven departure.

Who is Jeb Terry Sr., the new independent director at MDBH?

Jeb Terry Sr. is a seasoned investor with more than 20 years of experience in microcap medical and biotechnology companies, plus a background in venture capital, leveraged buyouts, international markets, and public equities, bringing a multifaceted investment and financial perspective to MDB Capital Holdings’ board.

How will MDBH compensate new director Jeb Terry Sr. for his board service?

MDB Capital Holdings will pay Jeb Terry Sr. an annual cash fee of $50,000 and grant options to acquire up to 100,000 Class A Shares under its 2022 Equity Incentive Plan, with a time-based vesting schedule tied to continued board service and subject to the company’s clawback policy.

What is the vesting schedule for Jeb Terry Sr.’s MDBH stock options?

Under the disclosed terms, 20,000 Class A Shares underlying Mr. Terry’s option vest on the first anniversary of the grant date. Thereafter, 5,000 additional Class A Shares vest at the end of each three-month period, provided he continues serving as a director through each vesting date.

Why did MDBH director Susanne Meline resign from the board?

MDB Capital Holdings stated that director Susanne Meline resigned effective February 1, 2026 as she begins to pursue her general retirement. The board accepted her resignation with regret and appreciation for her many years of service, with no adverse circumstances disclosed in the filing.

Does MDBH consider Jeb Terry an independent director and financial expert?

Yes. The board determined that Jeb Terry qualifies as an independent director under Nasdaq corporate governance standards and is a “financial expert” based on his extensive investment and business operational experience, supporting his role on MDB Capital Holdings’ audit committee.
MDB Capital Holdings LLC-A

NASDAQ:MDBH

MDBH Rankings

MDBH Latest News

MDBH Latest SEC Filings

MDBH Stock Data

31.43M
4.56M
11.54%
3.81%
0.03%
Capital Markets
Finance Services
Link
United States
DALLAS